Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.915
-0.105 (-2.09%)
At close: Oct 28, 2025, 4:00 PM EDT
4.910
-0.005 (-0.10%)
After-hours: Oct 28, 2025, 4:00 PM EDT

TriSalus Life Sciences Revenue

TriSalus Life Sciences had revenue of $11.21M in the quarter ending June 30, 2025, with 52.27% growth. This brings the company's revenue in the last twelve months to $35.99M, up 45.50% year-over-year. In the year 2024, TriSalus Life Sciences had annual revenue of $29.43M with 58.99% growth.

Revenue (ttm)
$35.99M
Revenue Growth
+45.50%
P/S Ratio
4.03
Revenue / Employee
$327,182
Employees
110
Market Cap
245.10M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 20205.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

TLSI News

More News